Bitcoin
103737
-49.43
-0.05%
Crude Oil
61.87
+0.25
+0.4%
Gold
3196.6
-30
-0.94%
Copper
4.59
-0.1
-2.08%
Silver
32.41
-0.27
-0.83%
Dow Jones
42322.75
+271.68
+0.64%
SP500
5947.78
+30.85
+0.52%
NASDAQ
19112.32
-34.49
-0.18%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
3.975
+99.00%
Top Gainers
5,881,031
Top Gainers
18.44
+99.00%
Top Gainers
1,908,745
Top Gainers
42.9
+99.00%
Top Gainers
160,678
Top Gainers
6.08
+99.00%
Top Gainers
225,049
Top Gainers
3.945
+64.01%
Top Gainers
644,067
Top Gainers
4.8774
+31.32%
Top Gainers
9,330,504
Top Gainers
1.555
+24.76%
Top Gainers
551,796
Top Gainers
26.1
+24.14%
Top Gainers
5,746,524
Top Gainers
5.46
+23.08%
Top Gainers
1,631,296
Top Gainers
7.87
+21.98%
Top Gainers
281,132
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
1415
-400.00%
Top Loosers
6,630,006
Top Loosers
9.11
-45.57%
Top Loosers
6,036,925
Top Loosers
21.6
-38.66%
Top Loosers
2,040,675
Top Loosers
1.335
-38.58%
Top Loosers
211,781
Top Loosers
7.125
-38.25%
Top Loosers
354,616
Top Loosers
2.8
-36.79%
Top Loosers
1,613,480
Top Loosers
13.01
-36.57%
Top Loosers
10,524,260
Top Loosers
1.19
-31.09%
Top Loosers
626,740
Top Loosers
101.94
-30.31%
Top Loosers
471,416
Top Loosers
16.83
-25.67%
Top Loosers
1,194,234
Top Loosers

In Today's Headlines

Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript
03:36
17 May 2025
Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript

Biofrontera Inc. (NASDAQ:BFRI ) Q1 2025 Earnings Conference Call May 16, 2025 10:00 AM ET Company Participants Andrew Barwicki - IR Representative Hermann Luebbert - CEO, Chairman, & Founder Fred Leffler - CFO Conference Call Participants Jonathan Aschoff - ROTH Capital Bruce Jackson - The Benchmark Company Operator Good day, and welcome to the Biofrontera's First Quarter 2025 Financial Results and Business Update Conference Call. All participants will be in listen-only mode.

Weekly Option Windfall: Leading Crypto Exchange Offers 34% Profit Potential
03:36
17 May 2025
Weekly Option Windfall: Leading Crypto Exchange Offers 34% Profit Potential

Outside of owning crypto outright, several stocks are making waves in conjunction with Bitcoin's ascent.

NextEra Outperforms Industry in Three Months: How to Play the Stock?
03:36
17 May 2025
NextEra Outperforms Industry in Three Months: How to Play the Stock?

NEE stock continues to gain from strengthening economic conditions in its service territories and rising demand driven by its expanding customer base.

Nvidia Plans Shanghai R&D Center, New Office Space in China, Report Says
03:35
17 May 2025
Nvidia Plans Shanghai R&D Center, New Office Space in China, Report Says

Nvidia (NVDA) reportedly plans to grow its presence in China with a new facility in Shanghai, even as the U.S. cracks down on the company's chip sales to the country.

ATTENTION NYSE: CODI INVESTORS: Contact Berger Montague About a Compass Diversified Holdings Class Action Lawsuit
03:33
17 May 2025
ATTENTION NYSE: CODI INVESTORS: Contact Berger Montague About a Compass Diversified Holdings Class Action Lawsuit

PHILADELPHIA , May 16, 2025 /PRNewswire/ --  Berger Montague PC  advises investors that a securities class action lawsuit has been filed against Compass Diversified Holdings ("Compass" or the "Company") (NYSE: CODI) on behalf of purchasers of Compass securities between May 1, 2024 through May 7, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Compass  securities during the Class Period may, no later than JULY 8, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline
03:30
17 May 2025
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148948&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

Expanse (GMGI) Completes Multiple U.S. Integrations and Launches New Flagship Slot
03:28
17 May 2025
Expanse (GMGI) Completes Multiple U.S. Integrations and Launches New Flagship Slot

Las Vegas, Nevada--(Newsfile Corp. - May 16, 2025) - Expanse Studios, the proprietary B2B game development unit of Golden Matrix Group Inc. (NASDAQ: GMGI), has successfully completed multiple new integrations across U.S.-focused social and sweepstakes casino platforms, alongside the official release of its newest flagship title, Gates of Olympia. To view the full announcement, including downloadable images, bios, and more, click here.

Compass Diversified (CODI) Faces Securities Class Action After Admitting to Accounting “Irregularities” – Hagens Berman
03:28
17 May 2025
Compass Diversified (CODI) Faces Securities Class Action After Admitting to Accounting “Irregularities” – Hagens Berman

SAN FRANCISCO, May 16, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Compass Diversified (NYSE: CODI) and certain of its executives after the company disclosed that it would restate its 2024 financial statements due to unrecorded financing arrangements and “irregularities” within its Lugano business unit. The suit, styled Matthews v. Compass Diversified Holdings, LLC, et al., No. 8:25-cv-00981 (C.D. Cal.), seeks to represent investors who purchased Compass Diversified securities between May 1, 2024 and May 7, 2025.

Novo Nordisk Stock: Seems Like A No-Brainer At These Levels
03:26
17 May 2025
Novo Nordisk Stock: Seems Like A No-Brainer At These Levels

Novo Nordisk A/S' share price decline is driven by negative sentiment despite strong sales growth, profitability, and efficiency metrics. Competition from Eli Lilly and supply issues have pressured market share, but Novo Nordisk remains highly profitable with a robust financial position. Recent CEO departure and pipeline setbacks have fueled pessimism, yet ongoing investments and U.S. expansion support long-term prospects.

QCOM Unveils Advanced Snapdragon 7 Chipset: Should You Buy the Stock?
03:26
17 May 2025
QCOM Unveils Advanced Snapdragon 7 Chipset: Should You Buy the Stock?

Qualcomm appears to be treading in the middle of the road, and investors could be better off if they trade with caution.